文献速递肿瘤 PET/CT

全身MRI与68Ga-PSMA PET/CT在前列腺癌根治术后生化复发检测中的前瞻性比较

Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-03-16

这项前瞻性试验纳入28例前列腺癌根治术后生化复发患者,均行全身MRI和68Ga-PSMA PET/CT检查;PET/CT在病灶检出率(100% vs 23.2%)和患者检出率(71.4% vs 39.3%)上均显著优于MRI,且诊断信心更高。

要点

  • 68Ga-PSMA PET/CT病灶检出率100%,全身MRI仅23.2%,差异有统计学意义。
  • 患者水平检出率PET/CT为71.4%,MRI为39.3%,差异有统计学意义。
  • PET/CT诊断信心评分2.7±0.7,高于MRI的2.3±0.6,差异有统计学意义。

核心结论

  • 在前列腺癌根治术后生化复发检测中,68Ga-PSMA PET/CT显著优于全身MRI。

研究设计与样本

  • 前瞻性试验纳入28例连续患者(平均年龄65.3±9.0岁),平均PSA 2.09±1.95 ng/ml,均行全身MRI和68Ga-PSMA PET/CT。

主要发现

  • 20例患者共检出56个病灶,PET/CT检出全部56个(100%),MRI检出13个(23.2%)。
  • 患者水平PET/CT检出20例(71.4%),MRI检出11例(39.3%),8例(28.6%)两种方法均未检出复发。
  • MRI检出的所有病灶均被PET/CT检出,PET/CT诊断信心评分更高(2.7±0.7 vs 2.3±0.6,p=0.044)。

关键数值与推荐

  • 病灶水平检出率比较p<0.001,患者水平比较p=0.0167。
  • 诊断信心采用三点Likert量表(1-3分),组间比较p=0.044。

临床怎么用

  • 对于前列腺癌根治术后生化复发患者,优先考虑68Ga-PSMA PET/CT进行复发灶检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess whole-body magnetic resonance imaging (wb-MRI) for detection of biochemical recurrence in comparison to 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography (68Ga-PSMA PET/CT) in prostate cancer (Pca) patients after radical prostatectomy. METHODS: This was a prospective trial including 28 consecutive patients (mean age 65.3 ± 9.0 years) with newly documented biochemical recurrence of Pca (mean prostate-specific antigen, PSA, 2.09 ± 1.95 ng/ml) following radical prostatectomy. All patients underwent both wb-MRI including a dedicated pelvic imaging protocol and PET/CT with 166 ± 35 MBq 68Ga-PSMA within a time window of 11 ± 10 days. PET/CT and MRI datasets were separately evaluated regarding Pca lesion count, type, localization and diagnostic confidence (three-point Likert scale, 1-3) by two nuclear medicine specialists and two radiologists, respectively. The reference standard was based on histopathological results, PSA levels following targeted salvage irradiation and follow-up imaging. Lesion-based and patient-based detection rates were compared using the chi-squared test. Differences in diagnostic confidence were assessed using the Welch test. RESULTS: A total of 56 Pca lesions were detected in 20 of the 28 patients. 68Ga-PSMA PET/CT detected 56 of 56 lesions (100%) in 20 patients (71.4%), while wb-MRI detected 13 lesions (23.2%) in 11 patients (39.3%). The higher detection rate with 68Ga-PSMA PET/CT was statistically significant on both a per-lesion basis (p < 0.001) and a per-patient basis (p = 0.0167). In 8 patients (28.6%) no relapse was detectable by either modality. All lesions detected by wb-MRI were also detected by 68Ga-PSMA PET/CT. Additionally, 68Ga-PSMA PET/CT provided superior diagnostic confidence in identifying Pca lesions (2.7 ± 0.7 vs. 2.3 ± 0.6, p = 0.044). CONCLUSION: 68Ga-PSMA PET/CT significantly out-performed wb-MRI in the detection of biochemical recurrence in Pca patients after radical prostatectomy.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Sawicki LM, Kirchner J, Buddensieck C, et al. Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2019. PMID: 30879122. doi:10.1007/s00259-019-04308-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。